Modular Medical, Inc.: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Nov 12, 2021 and accepted by EDGAR at Nov 12, 2021, 16:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2021-07-01 to 2021-09-30 | $2.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-04-01 to 2021-09-30 | $3.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-07-01 to 2021-09-30 | −$3.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-04-01 to 2021-09-30 | −$7.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $685.8k | us-gaap:InterestExpense |
| Interest expense | 6 months2021-04-01 to 2021-09-30 | $1.2m | us-gaap:InterestExpense |
| Income tax | 3 months2021-07-01 to 2021-09-30 | $1.6k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-04-01 to 2021-09-30 | $1.6k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-01 to 2021-09-30 | −$4.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-04-01 to 2021-09-30 | −$9.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-01 to 2021-09-30 | −$0.23 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2021-04-01 to 2021-09-30 | −$0.49 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2021-04-01 to 2021-09-30 | −$4.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-04-01 to 2021-09-30 | $22.8k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-09-30 | $798.2k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-09-30 | $844.7k | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $1.4m | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $6.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $6.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-09-30 | −$5.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001019056-21-000587. Last ingested by Listed: Nov 10, 2026, 07:32 ET. Listed shows no prices and gives no investment advice.